Tag: Aducanumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Aducanumab

Deep Dive: FDA's Accelerated Approval Pathway Under Fire - BioSpace

Added to Collection on: 2024-12-16 19:52:20

Tags for this article:

Food and Drug Administration
Biotechnology
Accelerated approval
Drug development
Orphan drugs
Aducanumab
Surrogate endpoint
Biogen
Gene therapy
Duchenne muscular dystrophy
Voxelotor
Delandistrogene moxeparvovec

Click the tags to see associated articles and topics

View Article Details
Rockefeller Neuroscience Institute enhances Alzheimer's treatment accessibility in West Virginia

Added to Collection on: 2024-12-17 02:39:28

Tags for this article:

Aging-associated diseases
Cognitive disorders
Learning disabilities
Alzheimer's disease
Dementia
Aducanumab
Lecanemab

Click the tags to see associated articles and topics

View Article Details
2024 Highlights the Rollercoaster That Is Neuro - BioSpace

Added to Collection on: 2024-12-23 05:06:03

Tags for this article:

Orphan drugs
Spinal muscular atrophy
Combination drugs
Azetidines
Emraclidine
Pyridines
Biogen
Xanomeline/trospium chloride
AbbVie
Bristol-Myers Squibb
Aducanumab
Alzheimer's disease
SAGE Therapeutics

Click the tags to see associated articles and topics

View Article Details
Vigil's TREM2-Targeted Alzheimer's Treatment Shows Early Promise, Moves on to Phase II

Added to Collection on: 2025-01-23 16:12:56

Tags for this article:

Alzheimer's disease
TREM2
Lecanemab
Trem
Biogen
Aducanumab
vigil neuroscience
Amgen

Click the tags to see associated articles and topics

View Article Details
FDA approves monthly maintenance dosing for Leqembi - LabPulse.com

Added to Collection on: 2025-01-29 23:24:45

Tags for this article:

Alzheimer's disease
Amyloidosis
Orphan drugs
Lecanemab
Biogen
Eisai
Amyloid beta
Maintenance dose
Phenytoin
MTOR
Aducanumab
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Is there an amyloid mafia? STAT readers weigh in

Added to Collection on: 2025-02-22 12:00:39

Tags for this article:

Alzheimer's disease
Amyloidosis
Biomarkers
Lecanemab
Amyloid beta
Donanemab
Aducanumab
Amyloid
Anti-amyloid drugs
Yo-El Ju

Click the tags to see associated articles and topics

View Article Details
Makary's 'Conditional Approval' Pathway for Rare Diseases Poses More Questions Than Answers

Added to Collection on: 2025-05-19 04:07:47

Tags for this article:

Drug discovery
Food and Drug Administration
Clinical research
Design of experiments
Accelerated approval
Drug development
Ultragenyx
Aducanumab
Sarepta Therapeutics
Emil Kakkis
Marty Makary
Orphan drug
Vinay Prasad

Click the tags to see associated articles and topics

View Article Details
Is Roche's new anti-amyloid drug a step forward for Alzheimer's disease treatment?

Added to Collection on: 2025-09-17 18:38:50

Tags for this article:

Amyloidosis
Histopathology
Alzheimer's disease
Anti-amyloid antibodies
Trontinemab
Lecanemab
Gantenerumab
Aducanumab
Donanemab
Amyloid-related imaging abnormalities
Biogen
Brainshuttle
Mitzi Gonzales

Click the tags to see associated articles and topics

View Article Details
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of - The National Law Review

Added to Collection on: 2025-09-29 01:57:08

Tags for this article:

Alzheimer's disease
Amyloidosis
Dementia
Lecanemab
Biogen
Eisai
Amyloid beta
Tauopathy
Insulin-degrading enzyme
MTOR
Aducanumab
Eisai Co . , Ltd
Eisai Inc.
China
Biogen Inc.

Click the tags to see associated articles and topics

View Article Details
Biogen Inc. (NASDAQ:BIIB) Receives Average Rating of “Hold” from Brokerages

Added to Collection on: 2025-09-30 06:31:59

Tags for this article:

Equity securities
Stock market
Biogen
Spinal muscular atrophy
Interferon beta-1a
Share
Stock
Short
Aducanumab
Price?earnings ratio
Investment

Click the tags to see associated articles and topics

View Article Details
Book a Demo